Good News: Ebola Vaccine For Humans Confirmed Ready

Upon successfully trying a promising Ebola vaccine on monkeys, the United States has started tracking Ebola vaccine on human beings.
The human trial of the vaccine is expected to be extended to Africa, where the virus disease has killed thousands, and the UK.
Experiments conducted by the US National Institutes of Health revealed that Monkeys developed long-term immunity to the virus ─ for as long as 10 months ─ after being exposed to the trial drug.
Upon successfully trying a promising Ebola vaccine on monkeys, the United States has started tracking Ebola vaccine on human beings.
The human trial of the vaccine is expected to be extended to Africa, where the virus disease has killed thousands, and the UK.
Experiments conducted by the US National Institutes of Health revealed that Monkeys developed long-term immunity to the virus ─ for as long as 10 months ─ after being exposed to the trial drug.
A BBC report informs that this treatment uses a genetically modified chimp virus containing components of two species of Ebola – Zaire, which is currently circulating in West Africa, and the common Sudan species. Since the viral vaccine does not replicate inside the body, it is hoped that the immune system gets to react to the Ebola component of the vaccine and develop anti-body.
More than 2,000 people have died in the outbreak of the deadly disease in West Africa, with Nigeria accounting for eight deaths, Liberia-1,089, Guinea -517 and Sierra Leone-491.
The disease was brought to Nigeria by a Liberian-American, Patrick Sawyer, who died in Lagos.